[Experience in the clinical use of Tavegyl in nose diseases--judgment of effectiveness by cross-over method].
D000328:Adult; D002986:Clinical Trials as Topic; D005260:Female; D006634:Histamine H1 Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011759:Pyrrolidines / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012852:Sinusitis / Q000188:drug therapy
D006634:Histamine H1 Antagonists; D010919:Placebos; D011759:Pyrrolidines